EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus

Jordi Camps iD, Simona Iftimie iD, Andrea Jiménez-Franco iD, Antoni Castro iD, Jorge Joven iD

Biomolecules · 16.07.2025 · 15 (7) · 1027

DOI: 10.3390/biom15071027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.07.2025. Verfasst von Jordi Camps und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Respiratory Syncytial Virus Infections, Influenza, Human. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 400 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory infections caused by severe acute respiratory syndrome coronavirus 2, influenza virus, and respiratory syncytial virus pose significant global health challenges, leading to high morbidity and mortality, particularly in vulnerable populations. Despite their distinct virological characteristics, these viruses exploit host cellular metabolism to support replication, modulate immune responses, and promote disease progression. Emerging evidence shows that they induce metabolic reprogramming, shifting cellular energy production toward glycolysis to meet the bioenergetic demands of viral replication. Additionally, alterations in lipid metabolism, including enhanced fatty acid synthesis and disrupted cholesterol homeostasis, facilitate viral entry, replication, and immune evasion. The dysregulation of mitochondrial function and oxidative stress pathways also contributes to disease severity and long-term complications, such as persistent inflammation and immune exhaustion. Understanding these metabolic shifts is crucial for identifying new therapeutic targets and novel biomarkers for early disease detection, prognosis, and patient stratification. This review provides an overview of the metabolic alterations induced by severe acute respiratory syndrome coronavirus 2, influenza virus, and respiratory syncytial virus, highlighting shared and virus-specific mechanisms and potential therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Respiratory Syncytial Virus InfectionsInfluenza, HumanHumansRespiratory Syncytial VirusesOrthomyxoviridaeMetabolic Reprogramming

Stichwörter der Autor:innen

infectious diseasesinfluenzametabolismrespiratory infectionsrespiratory syncytial virussevere acute respiratory syndrome coronavirus 2viral infections

Autor:innen und Institutionen

  • Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Catalonia, Spain.
  • Autoimmunity, Infection and Thrombosis Research Group (GRAIIT), Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr.…

ORCID-Profile: Jordi Camps, Simona Iftimie, Andrea Jiménez-Franco, Antoni Castro, Jorge Joven

Zitieren

APA

Camps, J., Iftimie, S., Jiménez-Franco, A., Castro, A., & Joven, J. (2025). Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus. Biomolecules, 15(7), 1027. https://doi.org/10.3390/biom15071027

Vancouver

Camps J, Iftimie S, Jiménez-Franco A, Castro A, Joven J. Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus. Biomolecules. 2025;15(7):1027. doi:10.3390/biom15071027

BibTeX
@article{Camps2025,
  author = {Camps, Jordi and Iftimie, Simona and Jiménez-Franco, Andrea and Castro, Antoni and Joven, Jorge},
  title = {Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial Virus},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {1027},
  doi = {10.3390/biom15071027}
}
Kostenlos starten →